[EN] GUANIDINE COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT<br/>[FR] COMPOSÉS ET COMPOSITIONS DE GUANIDINE POUR L'INHIBITION DE NAMPT
申请人:FORMA THERAPEUTICS INC
公开号:WO2012031199A1
公开(公告)日:2012-03-08
The present invention relates to compounds and compositions for the inhibition of NAMPT, their synthesis, applications and antidotes. An illustrative compound of the invention is shown below.
GUANIDINE COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT
申请人:Forma TM, LLC.
公开号:EP2611778A1
公开(公告)日:2013-07-10
US6255323B1
申请人:——
公开号:US6255323B1
公开(公告)日:2001-07-03
[EN] CYANOGUANIDINE COMPOUNDS<br/>[FR] COMPOSES A BASE DE CYANOGUANIDINE
申请人:SHIONOGI BIORESEARCH CORP
公开号:WO2000061561A1
公开(公告)日:2000-10-19
A cyanoguanidine compound of formula (I) is disclosed. A cyanoguanidine compound of the present invention possesses a high specificity for tumor cells. Also disclosed are methods for preparing a cyanoguanidine compound.
Cyanoguanidine compounds
申请人:Shionogi Bioresearch Corp.
公开号:US06255323B1
公开(公告)日:2001-07-03
A cyanoguanidine compound of the following formula:
is disclosed. A cyanoguanidine compound of the present invention possess a high specificity for tumor cells. Also disclosed are methods for preparing a cyanoguanidine compound.